Inventor · disambiguated record
Marc Mercken
Also filed as: KOYMANS LUCIEN MARIA HENRICUS · MERCKEN MARC · MERCKEN MARC H · MERCKEN MARC HUBERT
25 granted patents·12 pending applications·304 citations·filing 1993–2025
96Inventor score
Files withJANSSEN PHARMACEUTICA NV9INNOGENETICS NV8JANSSEN BIOTECH INC8MERCKEN MARC3MERCKEN MARC HUBERT3
Top patents by PatentIndex Score
37 records- 0196US11236155B2Antibodies to pyroglutamate amyloid-β and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 1, 2022·4 cites·23 claims
- 0293US11365244B2Anti-PHF-tau antibodies and uses thereofJANSSEN BIOTECH INC·Filed 2020·Granted Jun 21, 2022·4 cites·14 claims
- 0393US10766953B2Anti-PHF-tau antibodies and uses thereofJANSSEN BIOTECH INC·Filed 2018·Granted Sep 8, 2020·12 cites·40 claims
- 0493US6238892B1Monoclonal antibodies directed against the microtubule-associated protein tauINNOGENETICS NV·Filed 1996·Granted May 29, 2001·84 cites·3 claims
- 0591US10851156B2Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE Aβ antibodiesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Dec 1, 2020·8 cites·15 claims
- 0691US9371376B2Anti-PHF-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2012·Granted Jun 21, 2016·10 cites·11 claims
- 0790US10519223B2Antibodies to pyroglutamate amyloid-β and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 31, 2019·5 cites·16 claims
- 0889US6900293B2Monoclonal antibodies directed against the microtubule-associated protein tauINNOGENETICS NV·Filed 2000·Granted May 31, 2005·14 cites·8 claims
- 0988US10196440B2Anti-PHG-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2018·Granted Feb 5, 2019·3 cites·8 claims
- 1084US10000559B2Anti-PHF-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2017·Granted Jun 19, 2018·2 cites·18 claims
- 1183US8163873B2Isolated microtubule-associated protein tau peptides and kitMERCKEN MARC·Filed 2008·Granted Apr 24, 2012·11 cites·5 claims
- 1282US5843779AMonoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodiesINNOGENETICS NV·Filed 1993·Granted Dec 1, 1998·51 cites·2 claims
- 1380US2025320286A1Antibodies to pyroglutamate amyloid-b and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 1477US9939452B2N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and usesJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Apr 10, 2018·2 cites·2 claims
- 1577US6010913AIsolated human tau peptideINNOGENETICS NV·Filed 1995·Granted Jan 4, 2000·36 cites·2 claims
- 1677US5861257AMonoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applicationsINNOGENETICS NV·Filed 1995·Granted Jan 19, 1999·21 cites·4 claims
- 1776US10633435B2Anti-PHF-tau antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 28, 2020·1 cites·19 claims
- 1876US8461145B2Dibenzoazepine and dibenzooxazepine TRPA1 agonistsGIJSEN HENRICUS JACOBUS MARIA·Filed 2008·Granted Jun 11, 2013·3 cites·11 claims
- 1975US9745371B2Anti-PHF-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2016·Granted Aug 29, 2017·1 cites·15 claims
- 2074US2023047413A1Anti-PHF-Tau Antibodies and Uses ThereofJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2171US2022106387A1Antibodies to pyroglutamate amyloid-b and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2270US9329189B2N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositionsMERCKEN MARC HUBERT·Filed 2003·Granted May 3, 2016·6 cites·4 claims
- 2370US6232437B1Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.INNOGENETICS NV·Filed 1999·Granted May 15, 2001·25 cites·2 claims
- 2468US11673943B2Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jun 13, 2023·0 cites·21 claims
- 2567US8911731B2Monoclonal antibodies specific for beta-amyloid x-37 and uses thereofMERCKEN MARC HUBERT·Filed 2012·Granted Dec 16, 2014·1 cites·7 claims
- 2662US2003143760A1Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applicationsINNOGENETICS SA·Filed 2002·Application pending·0 cites
- 2761US12234280B2Anti-PHF-tau antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Feb 25, 2025·0 cites·10 claims
- 2857US2002001857A1Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applicationsINNOGENETICS NV·Filed 2001·Application pending·0 cites
- 2954US2005129695A1Anti-amyloid antibodies, compositions, methods and usesFiled 2004·Application pending·0 cites
- 3053US2006008853A1Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the sameINNOGENETICS NV·Filed 2004·Application pending·0 cites
- 3150US2023151083A1Anti-phf-tau antibodies and uses thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 3243US2010074901A1Human anti-amyloid antibodies, compositions, methods and usesMERCKEN MARC HUBERT·Filed 2008·Application pending·0 cites
- 3340US2006246075A1Anti-amyloid antibodies, compositions, methods and usesMERCKEN MARC·Filed 2005·Application pending·0 cites
- 3439US7183288B2Amide derivatives as glycogen synthase kinase 3-β inhibitorsFREYNE EDDY JEAN EDGARD·Filed 2002·Granted Feb 27, 2007·0 cites·13 claims
- 3539US2010028351A1Anti-amyloid antibodies, compositions, methods and usesMERCKEN MARC·Filed 2007·Application pending·0 cites
- 3638US2006063789A1Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitorsFREYNE EDDY JEAN E·Filed 2002·Application pending·0 cites
- 3736US8383637B22-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)JANSSSEN PHARMACEUTICA N V·Filed 2005·Granted Feb 26, 2013·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Marc Mercken files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →